Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Asb9 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Asb9 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ASB9 mRNA | CTD | PMID:16962184 | Asb9 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ASB9 mRNA | CTD | PMID:20106945 and PMID:21632981 | Asb9 | Rat | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Asb9 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of ASB9 exon | CTD | PMID:33297965 | Asb9 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Asb9 (Mus musculus) | 6480464 | bisphenol S affects the methylation of ASB9 gene | CTD | PMID:31683443 | Asb9 | Rat | 8'-apo-beta,psi-caroten-8'-al | increases expression | ISO | ASB9 (Homo sapiens) | 6480464 | apocarotenal results in increased expression of ASB9 mRNA | CTD | PMID:17034753 | Asb9 | Rat | aflatoxin B1 | decreases methylation | ISO | ASB9 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ASB9 intron | CTD | PMID:30157460 | Asb9 | Rat | aflatoxin B1 | affects expression | ISO | ASB9 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of ASB9 protein | CTD | PMID:20106945 | Asb9 | Rat | aflatoxin B1 | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of ASB9 mRNA | CTD | PMID:21632981 more ... | Asb9 | Rat | aflatoxin M1 | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of ASB9 mRNA | CTD | PMID:30928695 | Asb9 | Rat | all-trans-retinoic acid | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of ASB9 mRNA | CTD | PMID:23724009 | Asb9 | Rat | arsane | increases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Arsenic results in increased expression of ASB9 mRNA | CTD | PMID:38036231 | Asb9 | Rat | arsenic atom | increases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Arsenic results in increased expression of ASB9 mRNA | CTD | PMID:38036231 | Asb9 | Rat | arsenite(3-) | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to ASB9 mRNA] | CTD | PMID:32406909 | Asb9 | Rat | arsenous acid | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ASB9 protein] | CTD | PMID:26598702 | Asb9 | Rat | asbestos | affects expression | ISO | ASB9 (Homo sapiens) | 6480464 | Asbestos affects the expression of ASB9 mRNA | CTD | PMID:17297452 | Asb9 | Rat | azathioprine | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of ASB9 mRNA | CTD | PMID:22623647 | Asb9 | Rat | benzo[a]pyrene | affects methylation | ISO | ASB9 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ASB9 promoter | CTD | PMID:27901495 | Asb9 | Rat | benzo[a]pyrene | decreases methylation | ISO | ASB9 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ASB9 exon | CTD | PMID:27901495 | Asb9 | Rat | benzo[a]pyrene | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ASB9 mRNA | CTD | PMID:20106945 more ... | Asb9 | Rat | beta-carotene | increases expression | ISO | ASB9 (Homo sapiens) | 6480464 | beta Carotene results in increased expression of ASB9 mRNA | CTD | PMID:17034753 | Asb9 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ASB9 mRNA | CTD | PMID:25181051 | Asb9 | Rat | bisphenol A | affects expression | ISO | ASB9 (Homo sapiens) | 6480464 | bisphenol A affects the expression of ASB9 mRNA | CTD | PMID:30903817 | Asb9 | Rat | CGP 52608 | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ASB9 gene] | CTD | PMID:28238834 | Asb9 | Rat | cisplatin | increases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ASB9 mRNA | CTD | PMID:27392435 | Asb9 | Rat | cisplatin | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ASB9 mRNA | CTD | PMID:27392435 | Asb9 | Rat | copper atom | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ASB9 mRNA | CTD | PMID:20971185 | Asb9 | Rat | copper(0) | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of ASB9 mRNA | CTD | PMID:20971185 | Asb9 | Rat | copper(II) sulfate | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ASB9 mRNA | CTD | PMID:19549813 | Asb9 | Rat | cyclosporin A | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ASB9 mRNA | CTD | PMID:20106945 more ... | Asb9 | Rat | diarsenic trioxide | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ASB9 protein] | CTD | PMID:26598702 | Asb9 | Rat | dicrotophos | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of ASB9 mRNA | CTD | PMID:28302478 | Asb9 | Rat | diquat | increases expression | ISO | Asb9 (Mus musculus) | 6480464 | Diquat results in increased expression of ASB9 protein | CTD | PMID:36851058 | Asb9 | Rat | dorsomorphin | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Asb9 | Rat | folic acid | increases expression | ISO | Asb9 (Mus musculus) | 6480464 | Folic Acid results in increased expression of ASB9 mRNA | CTD | PMID:25629700 | Asb9 | Rat | formaldehyde | increases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of ASB9 mRNA | CTD | PMID:23649840 | Asb9 | Rat | genistein | decreases expression | ISO | Asb9 (Mus musculus) | 6480464 | Genistein results in decreased expression of ASB9 mRNA | CTD | PMID:32186404 | Asb9 | Rat | hydrogen peroxide | affects expression | ISO | ASB9 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of ASB9 mRNA | CTD | PMID:20044591 | Asb9 | Rat | ivermectin | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ASB9 protein | CTD | PMID:32959892 | Asb9 | Rat | lead diacetate | increases expression | ISO | Asb9 (Mus musculus) | 6480464 | lead acetate results in increased expression of ASB9 mRNA | CTD | PMID:22609695 | Asb9 | Rat | methyl methanesulfonate | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of ASB9 mRNA | CTD | PMID:23649840 | Asb9 | Rat | nickel atom | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Nickel results in decreased expression of ASB9 mRNA | CTD | PMID:24768652 and PMID:25583101 | Asb9 | Rat | panobinostat | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASB9 mRNA | CTD | PMID:27188386 | Asb9 | Rat | phenobarbital | multiple interactions | ISO | Asb9 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ASB9 mRNA] | CTD | PMID:19482888 | Asb9 | Rat | phenobarbital | decreases expression | ISO | Asb9 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of ASB9 mRNA | CTD | PMID:19482888 | Asb9 | Rat | phenylmercury acetate | increases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of ASB9 mRNA | CTD | PMID:26272509 | Asb9 | Rat | phenylmercury acetate | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASB9 mRNA | CTD | PMID:27188386 | Asb9 | Rat | pirinixic acid | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ASB9 mRNA | CTD | PMID:19710929 | Asb9 | Rat | quercetin | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ASB9 mRNA | CTD | PMID:21632981 | Asb9 | Rat | SB 431542 | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Asb9 | Rat | sodium arsenite | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ASB9 mRNA | CTD | PMID:29301061 and PMID:38568856 | Asb9 | Rat | sodium dichromate | increases expression | ISO | Asb9 (Mus musculus) | 6480464 | sodium bichromate results in increased expression of ASB9 mRNA | CTD | PMID:22155349 | Asb9 | Rat | sulforaphane | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of ASB9 mRNA | CTD | PMID:31838189 | Asb9 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of ASB9 mRNA | CTD | PMID:33387578 | Asb9 | Rat | trichostatin A | increases expression | ISO | ASB9 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of ASB9 mRNA | CTD | PMID:24935251 | Asb9 | Rat | urethane | decreases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Urethane results in decreased expression of ASB9 mRNA | CTD | PMID:28818685 | Asb9 | Rat | valproic acid | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASB9 mRNA | CTD | PMID:27188386 | Asb9 | Rat | valproic acid | affects expression | ISO | ASB9 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ASB9 mRNA | CTD | PMID:25979313 | Asb9 | Rat | valproic acid | increases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ASB9 mRNA | CTD | PMID:23179753 more ... | Asb9 | Rat | vorinostat | increases expression | ISO | ASB9 (Homo sapiens) | 6480464 | Vorinostat results in increased expression of ASB9 mRNA | CTD | PMID:26272509 | Asb9 | Rat | vorinostat | multiple interactions | ISO | ASB9 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASB9 mRNA | CTD | PMID:27188386 | |